Login / Signup

Long-Term Clinical Effectiveness of Ustekinumab in Patients With Crohn's Disease: A Retrospective Cohort Study.

Takahiro ItoAtsuo MaemotoTakehiko KatsuradaHiroki TanakaSatoshi MotoyaNobuhiro UenoMikihiro FujiyaToshifumi AshidaDaisuke HirayamaHiroshi Nakase
Published in: Crohn's & colitis 360 (2020)
Ustekinumab is effective and persistent in CD patients with the previous treatment history of several biologics.
Keyphrases
  • randomized controlled trial
  • systematic review
  • combination therapy